Endo Pharma's lower back pain drug fails trial Reuters June 30 (Reuters) – Endo Pharmaceuticals Holdings Inc said its experimental drug to treat lower back pain did not meet the goals of a mid-stage trial and it was evaluating the future of the drug. The drug, axomadol, was being tested against a placebo … Endo Pharmaceuticals back pain drug disappoints in trials Bizjournals.com Endo Pharma's Low- Back Pain Treatment Misses Study Goals NASDAQ Endo Pharmaceuticals Investor’s Business Daily MarketWatch (press release) all 20 news articles??
Read the original here:
Endo Pharma’s lower back pain drug fails trial – Reuters
